Of the four parts of the National Uniform Medication Program, the multiple medication violation penalty system has been adopted by the lowest number of jurisdictions. But one official April 11 said he expects that to change.
The first of a two-part column on regulatory medication thresholds. read blog
The American Quarter Horse Association said it remains committed to addressing misuse of medication in racing but a need for more resources has led it to suspend use of its multiple medication violation system pending review.
- By Tom LaMarra
- Horse Health, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlanic Region
The RMTC, which met Oct. 13, cited progress in state-by-state adoption of components of the National Uniform Medication Program and also added four drugs to the list of controlled substances.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium.
The Racing Medication and Testing Consortium hopes to have a recommended testing threshold level by late April for a naturally occurring amino acid that has a calming effect on racehorses.
As the Ohio State Racing Commission begins a comprehensive review of its medication rules and examines the National Uniform Medication Program, it has a hired a longtime veterinarian to consult on policies and procedures.
The Racing Medication and Testing Consortium may be close to recommending policy on the endogenous element cobalt, which when administered in high doses is believed to enhance production of red blood cells.
The Breeders' Cup World Championships will be held for the first time under reforms included in the National Uniform Medication Program.
When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
Most Popular Stories
- Nyquist Draws Post 13, is 3-1 Derby Favorite
- Unlocking Winners Kentucky Derby 142 Analysis
- Nancy From Nairobi Wins Royal Heroine
- Field of 22 Set for 142nd Kentucky Derby
- Team Optimistic, Nyquist 'Full of Energy'
- Beholder to Make 2016 Debut in Adoration
- Repole Returns With Outwork for Uncle Mo
- Big Blue Kitten Heads Woodford Turf Classic
- Lady Aurelia Awaits Queen Mary at Ascot
- Bensons Hope to Let Good Times Roll in Derby